Stay updated on Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added. The funding-notice banner and Revision: v3.4.1 were removed.SummaryDifference0.6%

- Check21 days agoChange DetectedA government funding notice banner and a software revision tag (v3.4.1) were added, with no changes to study data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check28 days agoChange DetectedUI updates to the history view introduce a glossary toggle, color-coded highlights for additions (green) and deletions (red), and revised revision labels (e.g., Revision: v3.4.0) and No FEAR Act Data wording.SummaryDifference0.8%

- Check42 days agoChange DetectedRevision: v3.3.4 was added to the history and Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded 'Revision: v3.3.3' and removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the footer area. These updates pertain to site release notes and navigation elements, not to core trial data.SummaryDifference0.2%

- Check85 days agoChange DetectedThe page history now shows Revision: v3.3.2 added and Revision: v3.3.1 deleted.SummaryDifference0.1%

Stay in the know with updates to Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page.